Milverine (drug)
![]() | |
| Clinical data | |
|---|---|
| Other names | Fenprin, Fenpyramine, Miospasm |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C20H20N2 |
| Molar mass | 288.394 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Milverine (Fenprin, Fenpyramine, Miospasm) is a spasmolytic (antispasmodic) agent that was developed in the latter half of the 20th century.[1][2][3]
The therapeutic use of fenpyramin as a platelet-antiaggregating and antithrombotic as well as vasodilating and antianginous medicine was also identified.[4]
Milverine is a bifunctional molecule; one half of the molecule contains 3,3-Diphenylpropylamine and the other half of the molecule contains fampridine.
Synthesis
The chemical synthesis of milverine was identified.[5]

Conjugate soft addition of benzene to cinnamic acid [140-10-3] (1) gives 3,3-diphenylpropionic acid [606-83-7] (2). Halogenation with thionyl chloride gives 3,3-diphenylpropionyl chloride [37089-77-3] (3). Schotten-Baumann reaction with 4-aminopyridine (Fampridine) [504-24-5] (4) gives 3,3-diphenyl-N-(4-pyridyl)propionamide [75437-13-7] (5). The last step involves reduction of the amide bond giving milverine (6), respectively.
References
- ^ Carpenedo F, Santi-Soncin E (May 1970). "[Spasmolytic activity of a new diphenylpropylaminic derivative, N-(4'-pyridyl)-3,3-diphenyl 1-aminopropane]". Minerva Medica (in Italian). 61 (43): 2417–24. PMID 5425728.
- ^ Baldi F, Ferrarini F, Balestra R, Borioni D, Longanesi A, Miglioli M (1984). "Effect of oral fenpyramine on meal-stimulated human sigmoid motility". Current Therapeutic Research. 36 (2): 267–272.
- ^ Fossati A, Sosio A, Pellegrini R, Frigo GM, D'Angelo L, Lecchini S, Marcoli M, Caravaggi M, Crema A (September 1986). "Milverine: in vitro and in vivo activity on the animal and human colon". Il Farmaco; Edizione Pratica. 41 (9): 279–89. PMID 3770157.
- ^ EP 0143082, Pellegrini R, Clavenna G, Bellani P, "Use of fenpyramin as platelet-antiaggregating, vasodilating, antithrombotic and antianginous medicine", assigned to Rbs Pharma (Roger Bellon Schoum) SpA
- ^ DE 3002909, Masi P, Monopoli A, Saravalle AC, Zio C, "Method for Producing N- (4'-Pyridyl)-3,3-diphenyl-propylamine", published 31 July 1980, assigned to Italiana Schoum Sp
